These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3323596

  • 1. A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis.
    West ML, Jindal KK, Bear RA, Goldstein MB.
    Kidney Int; 1987 Oct; 32(4):579-84. PubMed ID: 3323596
    [Abstract] [Full Text] [Related]

  • 2. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
    Jindal K, West M, Bear R, Goldstein M.
    Am J Kidney Dis; 1992 Jan; 19(1):61-7. PubMed ID: 1739084
    [Abstract] [Full Text] [Related]

  • 3. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
    Bruns FJ, Adler S, Fraley DS, Segel DP.
    Ann Intern Med; 1991 May 01; 114(9):725-30. PubMed ID: 2012353
    [Abstract] [Full Text] [Related]

  • 4. Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy.
    Alexopoulos E, Sakellariou G, Memmos D, Karamitsos K, Leontsini M, Papadimitriou M.
    Am J Kidney Dis; 1993 May 01; 21(5):497-503. PubMed ID: 8488817
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct 01; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 6. Membranous glomerulonephritis: treatment response and outcome in children.
    Valentini RP, Mattoo TK, Kapur G, Imam A.
    Pediatr Nephrol; 2009 Feb 01; 24(2):301-8. PubMed ID: 18846392
    [Abstract] [Full Text] [Related]

  • 7. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec 01; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
    Chen Y, Deng Y, Ni Z, Chen N, Chen X, Shi W, Zhan Y, Yuan F, Deng W, Zhong Y.
    Am J Kidney Dis; 2013 Dec 01; 62(6):1068-76. PubMed ID: 23810688
    [Abstract] [Full Text] [Related]

  • 9. Treatment aspects of primary nephrotic syndrome in adults.
    Rasić S, Uncanin S, Dzemidzić J, Aganović K, Srna A, Rasić I.
    Bosn J Basic Med Sci; 2006 May 01; 6(2):16-20. PubMed ID: 16879107
    [Abstract] [Full Text] [Related]

  • 10. Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.
    Falk RJ, Hogan SL, Muller KE, Jennette JC.
    Ann Intern Med; 1992 Mar 15; 116(6):438-45. PubMed ID: 1371211
    [Abstract] [Full Text] [Related]

  • 11. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
    Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB.
    Am J Nephrol; 2001 Sep 01; 21(2):128-33. PubMed ID: 11359020
    [Abstract] [Full Text] [Related]

  • 13. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA.
    Nephron; 1987 Sep 01; 46(1):73-7. PubMed ID: 3600915
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.
    Liu Y, Qu X, Chen W, Zhang Y, Liu L.
    Ren Fail; 2016 Nov 01; 38(10):1616-1621. PubMed ID: 27819170
    [Abstract] [Full Text] [Related]

  • 15. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
    Muslimović A, Rasić S, Rebić D, Uncanin S.
    Med Arh; 2009 Nov 01; 63(4):187-90. PubMed ID: 20088170
    [Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA, Lien JW, Aber GM.
    Clin Nephrol; 1979 Jan 01; 11(1):26-30. PubMed ID: 428152
    [Abstract] [Full Text] [Related]

  • 17. Controlled trial of prednisone in adult patients with the nephrotic syndrome.
    Black DA, Rose G, Brewer DB.
    Br Med J; 1970 Aug 22; 3(5720):421-6. PubMed ID: 4916790
    [Abstract] [Full Text] [Related]

  • 18. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF, Farine M, Thorner P, Baumal R.
    Clin Nephrol; 1984 Sep 22; 22(3):109-13. PubMed ID: 6488594
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
    J Am Soc Nephrol; 2007 Jun 22; 18(6):1899-904. PubMed ID: 17494881
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov 22; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.